Randomized Controlled Trial: Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
23 May, 2018 | 12:13h | UTCCanakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Autoinflammatory Syndromes Show Dramatic Response to Canakinumab – RheumNow (free)